Re: Vaccines and Therapeutics 2.0 & 3.0 Merge
Posted: Thu Jan 20, 2022 6:34 am
Roberts issued a subsequent statement Wednesday saying he “did not request Justice Gorsuch or any other Justice to wear a mask on the bench
Internet Mormons, Chapel Mormons, Critics, Apologists, and Never-Mo's all welcome!
https://discussmormonism.com/
Roberts issued a subsequent statement Wednesday saying he “did not request Justice Gorsuch or any other Justice to wear a mask on the bench
I just read the article. But, my position still stands. If a treatment doesn't harm, or if a doctor believes the risks outweigh the benefits, why not let doctors use it. Each person is a little different and while it may not work for some, it may work for others. The decision should remain with the doctor and the patient after informed consent. Politics need to take a back seat here.
Oh I dunno. Maybe the FDA is worried about things like whether the treatment actually has any scientifically verifiable effect? You know, elite stuff like that.
Serious medical treatment for life threatening conditions is not really some kind of 'I never liked vanilla Ice cream, but have some if you enjoy it" kind of thing.
A one size fits all type of solution for a virus that affects different sets of the population differently is a mistake. Let's increase the arsenal, not limit it to a favored solution or solutions. First do no harm should apply to the FDA as well. Frankly, I don't know how they so quickly determined that monoclonal antibodies were ineffective against omicron. The thing has only been around for a couple of months.Chap wrote: ↑Tue Jan 25, 2022 8:58 pmOh I dunno. Maybe the FDA is worried about things like whether the treatment actually has any scientifically verifiable effect? You know, elite stuff like that.
Serious medical treatment for life threatening conditions is not really some kind of 'I never liked vanilla Ice cream, but have some if you enjoy it" kind of thing.
I think of the pandemic as more of a triage than palliative care. Do hospitals have the resources to ‘try out’ experimental treatments right now to see what sticks? Let the private practices do that, have them submit their findings, and then see what sticks. Who knows. Maybe shoving a lightbulb up one’s ass while guzzling horse paste might be the way to go, but I’m not sure General Hospital has the ability to “F” around with programs right now.Dr Exiled wrote: ↑Tue Jan 25, 2022 9:16 pmA one size fits all type of solution for a virus that affects different sets of the population differently is a mistake. Let's increase the arsenal, not limit it to a favored solution or solutions. First do no harm should apply to the FDA as well. Frankly, I don't know how they so quickly determined that monoclonal antibodies were ineffective against omicron. The thing has only been around for a couple of months.Chap wrote: ↑Tue Jan 25, 2022 8:58 pm
Oh I dunno. Maybe the FDA is worried about things like whether the treatment actually has any scientifically verifiable effect? You know, elite stuff like that.
Serious medical treatment for life threatening conditions is not really some kind of 'I never liked vanilla Ice cream, but have some if you enjoy it" kind of thing.
So this guy is right?K Graham wrote: ↑Tue Jan 25, 2022 11:09 pmNew study suggests two paths toward ‘super immunity’ to COVID-19
A new study finds that two forms of immunity — breakthrough infections following vaccination or natural infection followed by vaccination — provide roughly equal levels of enhanced immune protection. The study published online today in the journal Science Immunology.
“It makes no difference whether you get infected and then vaccinated, or if you get vaccinated and then a breakthrough infection,” said co-senior author Fikadu Tafesse, Ph.D., assistant professor of molecular microbiology and immunology in the OHSU School of Medicine. “In either case, you will get a really, really robust immune response — amazingly high.”
The research follows an OHSU study published in December that described extremely high levels of immune response following breakthrough infections — so-called “super immunity.” That study was the first to use multiple live SARS-CoV-2 variants to measure cross-neutralization of blood serum from breakthrough cases.